Allrock Bio
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Washington St Fl 2, Natick, Massachus...Website
www.allrockbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Allrock Bio
AllRock Bio is a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases. The company's lead candidate, ROC-101, is a first-in-class, oral pan-ROCK inhibitor being developed to address the urgent unmet need in pulmonary arterial hypertension (PAH) and other life-threatening fibrotic diseases. With a seasoned leadership team and a commitment to addressing unmet need, AllRock is dedicated to bringing a new class of disease-modifying therapies to patients.Explore more
Allrock Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allrock Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Allrock Bio is spiking on competitors!
Product Launch: Get notified when Allrock Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at Allrock Bio
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Allrock Bio recently announced quarterly report
Allrock Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Allrock Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Allrock Bio has new funding data
Click to see if Allrock Bio had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Allrock Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Allrock Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Allrock Bio.
Allrock Bio financials insights
Gather financial insights about Allrock Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$50M
Allrock Bio News & Media
AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress
ROC-101 exhibits favorable pharmacokinetics for once-daily dosing Data support the potential therapeutic efficacy of ROC-101; justify further development via a Phase 2, proof-of-concept trial in patients with PAH or ILD-PH slated to begin Q4 2025 NATICK, Mass., Sept. 29, 2025 /PRNewswire/...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allrock Bio
Sign Up For FreeTo access detailed company insights
AllRock Bio is a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases. The company's lead candidate, ROC-101, is a first-in-class, oral pan-ROCK inhibitor being developed to address the urgent unmet need in pulmonary arterial hypertension (PAH) and other life-threatening fibrotic diseases. Wi... Read More
